These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 7771056)
1. Immunoreactivity of canine transitional cell carcinoma of the urinary bladder with monoclonal antibodies to tumor-associated glycoprotein 72. Clemo FA; DeNicola DB; Carlton WW; Walker E; Morrison WB Vet Pathol; 1995 Mar; 32(2):155-61. PubMed ID: 7771056 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical evaluation of canine carcinomas with monoclonal antibody B72.3. Clemo FA; DeNicola DB; Delaney LJ Vet Pathol; 1993 Mar; 30(2):140-5. PubMed ID: 8470336 [TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of canine epithelial and nonepithelial neoplasms with monoclonal antibody B72.3. Clemo FA; DeNicola DB; Morrison WB; Carlton WW Vet Pathol; 1995 Mar; 32(2):147-54. PubMed ID: 7771055 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders. Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of immunoreactivity of normal tissues from dogs, using monoclonal antibody B72.3. Clemo FA; DeNicola DB; Zimmermann JL Am J Vet Res; 1994 Aug; 55(8):1139-47. PubMed ID: 7978655 [TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of canine mammary neoplasms with monoclonal antibody CC49. Shahar R; Harmelin A; Shamir MH; Schneebaum S Zentralbl Veterinarmed A; 1997 Aug; 44(6):317-23. PubMed ID: 9342924 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1. Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496 [TBL] [Abstract][Full Text] [Related]
8. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture. Johnston WW Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301 [TBL] [Abstract][Full Text] [Related]
9. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder. Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252 [TBL] [Abstract][Full Text] [Related]
10. Lewis X antigen immunostaining in the diagnosis of transitional cell carcinoma. Loy TS; Alexander CJ; Calaluce RD Mod Pathol; 1995 Aug; 8(6):587-90. PubMed ID: 8532688 [TBL] [Abstract][Full Text] [Related]
11. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3. Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078 [TBL] [Abstract][Full Text] [Related]
12. Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder. Suárez-Bonnet A; Herráez P; Aguirre M; Suárez-Bonnet E; Andrada M; Rodríguez F; Espinosa de Los Monteros A Urol Oncol; 2015 Jul; 33(7):332.e1-7. PubMed ID: 25979650 [TBL] [Abstract][Full Text] [Related]
13. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Sheer DG; Schlom J; Cooper HL Cancer Res; 1988 Dec; 48(23):6811-8. PubMed ID: 3180090 [TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue. Molinolo A; Simpson JF; Thor A; Schlom J Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774 [TBL] [Abstract][Full Text] [Related]
15. Applications of immunocytochemistry to clinical cytology. Johnston WW; Szpak CA; Thor A; Simpson JF; Schlom J Cancer Invest; 1987; 5(6):593-611. PubMed ID: 3327572 [TBL] [Abstract][Full Text] [Related]
16. Reactivity of the monoclonal antibody B72.3 with fetal antigen: correlation with expression of TAG-72 in human carcinomas. Stanick D; Schuss A; Mishriki Y; Chao S; Thor A; Lundy J Cancer Invest; 1988; 6(3):279-87. PubMed ID: 3048576 [TBL] [Abstract][Full Text] [Related]
17. Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study. Zorzos J; Zizi A; Bakiras A; Pectasidis D; Skarlos DV; Zorzos H; Elemenoglou J; Likourinas M Eur Urol; 1995; 28(3):251-4. PubMed ID: 8536781 [TBL] [Abstract][Full Text] [Related]
18. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma. Vinall RL; Kent MS; deVere White RW Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors. Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713 [TBL] [Abstract][Full Text] [Related]
20. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders. Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]